Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01898650 · ClinicalTrials.gov registry record · NA

MRI for Non-invasive Evaluation of Brain Stress

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT01898650: Completed NA study, sponsored by Washington University School of Medicine.

NCT01898650 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01898650, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

Craniosynostosis is a birth defect that causes the bones on a baby's head to fuse together earlier than normal. This causes the baby to have an abnormally shaped head. These children are operated on to prevent or treat increased pressure on the brain, allowing for normal development. There is not good evidence of which children with craniosynostosis have increased pressure on the brain. Up to twenty patients with craniofacial abnormalities will be enrolled in this pilot study. The investigators will use a magnetic resonance scanner to obtain several measures of brain metabolism. The investigators will also obtain data which are markers of developmental delay. The results will also be compared to age and gender matched data from children without craniofacial abnormalities. There study hypothesis is that patients with craniofacial abnormalities associated with intracranial pressure will have decreased metabolic activity compared to control patients.

Primary Outcome

To be measured with both oxygen extraction fraction and arterial spin labeling to measure blood flow.

Interventions

  • OTHER MR scan

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2013-01-30
Est. Completion 2017-07
Phase NA

What the finished NCT01898650 record still lists

NCT01898650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which MR scan is the first listed.

NCT01898650 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01898650 about?

NCT01898650 is a clinical study titled "MRI for Non-invasive Evaluation of Brain Stress". Craniosynostosis is a birth defect that causes the bones on a baby's head to fuse together earlier than normal. This causes the baby to have an abnormally shaped head. These children are operated on to prevent or treat increased pressure on the brain, allowing for normal development. There is not go...

What is the current status of trial NCT01898650?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2013-01-30. Estimated completion is 2017-07.

What interventions are being tested in trial NCT01898650?

The interventions under investigation include: MR scan (OTHER).

Who is sponsoring clinical trial NCT01898650?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01898650's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01898650, the US trial registry maintained by the National Library of Medicine. NCT01898650 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.